Address
Road no. 4, Vatara, Notun Bazar
Dhaka, Bangladesh
Address
Road no. 4, Vatara, Notun Bazar
Dhaka, Bangladesh

Product Name: Rematib
Generic: Upadacitinib
Indications: Rheumatoid arthritis, Psoriatic arthritis, and Atopic dermatitis
Strength: 15 mg
Each pack contains: 28 tablets
Rematib 15 mg is an oral medication approved for treating autoimmune conditions like rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and atopic dermatitis. It was approved for patients who did not respond well to other treatments. It works by selectively inhibiting Janus kinase (JAK1), an enzyme involved in inflammation signaling, helping reduce pain and swelling. In Bangladesh, Rematib 15 mg is available through authorized pharmaceutical distributors and hospital pharmacies.
Rematib 15 mg tablet received FDA approval in May 2023 for the following indications
Not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or potent immunosuppressants such as azathioprine and cyclosporine.
Rematib 15 mg works by blocking an enzyme called Janus kinase 1 (JAK1), which sends signals that cause inflammation in the body. Reducing these signals, it helps decrease pain, swelling, and tissue damage in autoimmune conditions like arthritis, eczema, and inflammatory bowel diseases.
15 mg daily once in adult patients with or without food as a whole tablet without splitting or crushing it.
The recommended dose is 15 mg daily for pediatric patients aged 12 years or older that, at least 40 kg. If the therapeutic response is not reached dose can be increased by 30 mg daily once. Even after that, if a therapeutic response is not received, patients should discontinue taking Rematib.
The initial dose is 30 mg daily by mouth for 12 weeks or until disease progression. Dose can be modified or continued as 30 mg with your doctor’s permission. To treat eczema, the initial dose is 30 mg daily by mouth for 8 weeks or until disease progression.
To treat ulcerative colitis, the recommended dose is 45 mg daily by mouth for 8 weeks. If anything severe happens, consider 30 mg daily or consult with your doctor.
Take 15 mg daily by mouth to treat those patients who have had an inadequate response or intolerance to ≥1 TNF blocker.
Rematib 15 mg tablet (Upadacitinib) can cause some mild to serious side effects in patients with or without pre-existing critical health conditions. The chance of getting serious side effects is high for pre-existing critical medical conditions. Let’s have a look at some common and serious side effects that are being seen in the patients:
There are some factors for which you can choose Rematib over other branded medicines, like
Store Rematib 15 mg package below 25 degrees C away from direct sunlight and children.
Upadacitinib 15 mg (Rematib) price depends on available brands, manufacturing quality, and regulatory authority approval. Rematib is a generic brand manufactured in Bangladesh, available for export, and costs less than other branded medications. This medication is typically available through licensed hospital pharmacies or registered distributors. The per-month cost of this medication depends on treatment duration and suggested doses. Your health care provider may estimate the per-month cost of this medication.
The price is higher in the UK, which can be a couple of thousand GBP if it is not under the medical insurance. If you are looking for low-cost rheumatoid arthritis treatment, you may go for the generic versions available in the market with your healthcare provider’s suggestion.
Yes. Weight gain is a reported side effect, especially in patients with atopic dermatitis. Though the ratio is low, discuss with your healthcare provider if it becomes a matter of concern.
Individual responses vary patient to patient. Some patients start feeling better within days, and significant improvement is often seen between 2 and 8 weeks for many conditions. Full therapeutic effect can take up to 3 months.
Upadacitinib is a newer, selective Janus kinase 1 (JAK1) inhibitor, while tofacitinib inhibits JAK1 and JAK3. In studies comparing them for conditions like ulcerative colitis, upadacitinib has shown higher efficacy for inducing remission but also a higher incidence of adverse events, like acne.
Upadacitinib 15 mg (Rematib) can be purchased online from licensed pharmacies or authorized medical suppliers. Always verify the pharmacy’s credentials, ensure a valid prescription is required, and confirm product authenticity and shipping regulations before completing the purchase to ensure safe access.
Disclaimer: Information above is not for use as a medical advice alternative; always consult your doctor before taking any prescription medicines.
Reviews
There are no reviews yet.